Our neuroscience experts are headed to Madrid for the 17th annual Clinical Trials on Alzheimer's Disease (CTAD) conference! Will we see you there? Schedule a meeting during the show to learn how our network of clinical research sites prioritizes the participant experience and use of best practice strategies to achieve large-volume recruitment and retention of diverse populations for Alzheimer's disease research while delivering the highest quality data for our sponsor/CRO partners.
Email a team members to schedule a meeting:
• Donald Marks, Founder and President of Headlands Research EMA, a Headlands Research clinical site
• Mark Goldstein, Co-founder and President of JEM Research Institute, a Headlands Research clinical site
• Linda Pao, Principal Investigator at JEM Research Institute, a Headlands Research clinical site
• Kelly Douglas, Sub-Investigator at JEM Research Institute, a Headlands Research clinical site